Ogura, A., Akiyoshi, T., Yamamoto, N., Kawachi, H., Ishikawa, Y., Mori, S., … Ueno, M. (2018). Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer. European Journal of Cancer (Oxford, England : 1990), 91, 11-20. https://doi.org/10.1016/j.ejca.2017.12.005 (Original work published 2018)

Kanauchi, O., Andoh, A., AbuBakar, S., & Yamamoto, N. (2018). Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune Systems. Current Pharmaceutical Design. https://doi.org/10.2174/1381612824666180116163411 (Original work published 2018)

Wu, Y., Yang, J., Kim, D., Lu, S., Zhou, J., Seto, T., … Goto, K. (2018). Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(14), 1405-1411. https://doi.org/10.1200/JCO.2017.75.5587 (Original work published 2018)

Fujiwara, Y., Kenmotsu, H., Yamamoto, N., Shimizu, T., Yonemori, K., Ocampo, C., … Murakami, H. (2021). Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors. Cancer Medicine, 10(7), 2350-2358. https://doi.org/10.1002/cam4.3815